FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2968139807> ?p ?o ?g. }

• W2968139807 endingPage "1719" @default.
• W2968139807 startingPage "1710" @default.
• W2968139807 abstract "Sickle cell disease afflicts millions of people worldwide and approximately 100,000 Americans. Complications are myriad and arise as a result of complex pathological pathways ‘downstream’ to a point mutation in DNA, and include red blood cell membrane damage, inflammation, chronic hemolytic anemia with episodic vaso-occlusion, ischemia and pain, and ultimately risk of cumulative organ damage with reduced lifespan of affected individuals. The National Heart, Lung, and Blood Institute’s 2014 evidence-based guideline for sickle cell disease management states that additional research is needed before investigational curative therapies will be widely available to most patients with sickle cell disease. To date, sickle cell disease has been cured by hematopoietic stem cell transplantation in approximately 1,000 people, most of whom were children, and significantly ameliorated by gene therapy in a handful of subjects who have only limited follow-up thus far. During a timespan in which over 20 agents were approved for the treatment of cystic fibrosis by the Food and Drug Administration, similar approval was granted for only two drugs for sickle cell disease (hydroxyurea and L-glutamine) despite the higher prevalence of sickle cell disease. This trajectory appears to be changing, as the lack of multimodal agent therapy in sickle cell disease has spurred engagement among many in academia and industry who, in the last decade, have developed new drugs poised to prevent complications and alleviate suffering. Identified therapeutic strategies include fetal hemoglobin induction, inhibition of intracellular HbS polymerization, inhibition of oxidant stress and inflammation, and perturbation of the activation of the endothelium and other blood components (e.g. platelets, white blood cells, coagulation proteins) involved in the pathophysiology of sickle cell disease. In this article, we present a crash-course review of disease-modifying approaches (minus hematopoietic stem cell transplant and gene therapy) for patients with sickle cell disease currently, or recently, tested in clinical trials in the era following approval of hydroxyurea." @default.
• W2968139807 created "2019-08-22" @default.
• W2968139807 creator A5019340839 @default.
• W2968139807 creator A5070730284 @default.
• W2968139807 date "2019-08-14" @default.
• W2968139807 modified "2023-09-30" @default.
• W2968139807 title "Emerging disease-modifying therapies for sickle cell disease" @default.
• W2968139807 cites W109685203 @default.
• W2968139807 cites W126726036 @default.
• W2968139807 cites W1492560350 @default.
• W2968139807 cites W1524961767 @default.
• W2968139807 cites W1547834900 @default.
• W2968139807 cites W1562443263 @default.
• W2968139807 cites W1566850314 @default.
• W2968139807 cites W1584253018 @default.
• W2968139807 cites W171117290 @default.
• W2968139807 cites W1771805953 @default.
• W2968139807 cites W1774477583 @default.
• W2968139807 cites W1919238100 @default.
• W2968139807 cites W1931426230 @default.
• W2968139807 cites W1955305991 @default.
• W2968139807 cites W1980573671 @default.
• W2968139807 cites W1982780294 @default.
• W2968139807 cites W1983823043 @default.
• W2968139807 cites W1992294822 @default.
• W2968139807 cites W1993862026 @default.
• W2968139807 cites W1995698717 @default.
• W2968139807 cites W2000816039 @default.
• W2968139807 cites W2008533018 @default.
• W2968139807 cites W2015929262 @default.
• W2968139807 cites W2020493440 @default.
• W2968139807 cites W2020634990 @default.
• W2968139807 cites W2023388917 @default.
• W2968139807 cites W2027816595 @default.
• W2968139807 cites W2029724982 @default.
• W2968139807 cites W2035346271 @default.
• W2968139807 cites W203611039 @default.
• W2968139807 cites W2038576339 @default.
• W2968139807 cites W2040213541 @default.
• W2968139807 cites W2040548547 @default.
• W2968139807 cites W2052525169 @default.
• W2968139807 cites W2053677349 @default.
• W2968139807 cites W2055155035 @default.
• W2968139807 cites W2058122189 @default.
• W2968139807 cites W2066501708 @default.
• W2968139807 cites W2073869392 @default.
• W2968139807 cites W2077716817 @default.
• W2968139807 cites W2083399493 @default.
• W2968139807 cites W2087176502 @default.
• W2968139807 cites W2096190607 @default.
• W2968139807 cites W2104724413 @default.
• W2968139807 cites W2104995733 @default.
• W2968139807 cites W2112671019 @default.
• W2968139807 cites W2115068232 @default.
• W2968139807 cites W2115206864 @default.
• W2968139807 cites W2119580559 @default.
• W2968139807 cites W2139585567 @default.
• W2968139807 cites W2139863296 @default.
• W2968139807 cites W2140551282 @default.
• W2968139807 cites W2144684129 @default.
• W2968139807 cites W2149270461 @default.
• W2968139807 cites W2155803841 @default.
• W2968139807 cites W2163969168 @default.
• W2968139807 cites W2167036604 @default.
• W2968139807 cites W2169500192 @default.
• W2968139807 cites W2170077226 @default.
• W2968139807 cites W2171937459 @default.
• W2968139807 cites W2187604395 @default.
• W2968139807 cites W2215583678 @default.
• W2968139807 cites W2255869136 @default.
• W2968139807 cites W2293470323 @default.
• W2968139807 cites W2295195689 @default.
• W2968139807 cites W2326476344 @default.
• W2968139807 cites W2329123120 @default.
• W2968139807 cites W2334263927 @default.
• W2968139807 cites W2339933044 @default.
• W2968139807 cites W2342636415 @default.
• W2968139807 cites W2436903794 @default.
• W2968139807 cites W2468870776 @default.
• W2968139807 cites W25054622 @default.
• W2968139807 cites W2522156785 @default.
• W2968139807 cites W2532541640 @default.
• W2968139807 cites W2559643145 @default.
• W2968139807 cites W2584418414 @default.
• W2968139807 cites W2592339311 @default.
• W2968139807 cites W2598384706 @default.
• W2968139807 cites W2599692870 @default.
• W2968139807 cites W2604819493 @default.
• W2968139807 cites W2605267194 @default.
• W2968139807 cites W2609647412 @default.
• W2968139807 cites W2684890715 @default.
• W2968139807 cites W2732958242 @default.
• W2968139807 cites W2749848699 @default.
• W2968139807 cites W2751645476 @default.
• W2968139807 cites W2769840018 @default.
• W2968139807 cites W2778831181 @default.
• W2968139807 cites W2782382390 @default.
• W2968139807 cites W2783726191 @default.

• next